EFFECTS OF ANABOLIC STEROIDS ON DIABETIC INSTABILITY.
D045930:Anabolic Agents; D001774:Blood Chemical Analysis; D003920:Diabetes Mellitus; D003928:Diabetic Nephropathies; D004358:Drug Therapy; D006937:Hypercholesterolemia; D006949:Hyperlipidemias; D007004:Hypoglycemic Agents; D008660:Metabolism; D008696:Methandrostenolone; D010024:Osteoporosis; D013197:Stanozolol; D013256:Steroids; D013739:Testosterone / Q000627:therapeutic use*; D014116:Toxicology; D014556:Urine
D045930:Anabolic Agents; D007004:Hypoglycemic Agents; D013256:Steroids; D013739:Testosterone; D013197:Stanozolol; D008696:Methandrostenolone
ANABOLIC STEROIDS; ANTIDIABETICS; BLOOD CHEMICAL ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DRUG THERAPY; HYPERCHOLESTEREMIA; HYPERLIPEMIA; METABOLISM; METHANDROSTENOLONE; OSTEOPOROSIS; STANOZOLOL; TESTOSTERONE, THERAPEUTIC; TOXICOLOGIC REPORT; URINE